A bug increases the risks of colon cancer

A bug increases the risks of colon cancer

Indian researchers have identified a new gut-inhabiting bacterium that increases the risk of colon cancer1. This bacterium can break down chemicals with anticancer properties called flavonoids, which humans get from edible plants and fruits. The researchers have found that colon cancer patients have a higher number of this bacterium than healthy individuals. They say thisRead more about A bug increases the risks of colon cancer[…]

Liquid biopsy to hunt down deadly tumours

Liquid biopsy to hunt down deadly tumours

Researchers have developed a system that can detect, capture and remove tumour cells circulating in the peripheral bloodstream, making it potentially useful for diagnosing and treating cancers. Primary tumours shed cells which circulate in the bloodstream, eventually forming masses in organs, a process known as metastasis. Circulating tumour cells are promising cancer biomarkers. Using magneticRead more about Liquid biopsy to hunt down deadly tumours[…]

New arsenal against drug-resistant cancers

New arsenal against drug-resistant cancers

Combining camptothecin, a well-known anticancer alkaloid, with veliparib, an anticancer agent still under clinical trial, researchers have reported good results in treating drug-defying cancers of the breast, ovary, lungs and colon1. The combination therapy kills the cancer cells by inhibiting the activity of two key enzymes that orchestrate DNA replication, protein synthesis and DNA repairRead more about New arsenal against drug-resistant cancers[…]